CNS drugs that succeed require human brain data. We make the inner frontier accessible.

Crownlands Medicine introduces Gateway, the drug development platform that brings human neuron data into the preclinical phase.

People, not induced models, show us the drivers of neurodegenerative disease and drug response.

Crownlands Gateway technology sequences human neurons one synapse away from the brain — collected noninvasively at unmatched scale.

Reach out to learn more about our programs.